Wiley Bros. Aintree Capital, LLC Insulet Corp Transaction History
Wiley Bros. Aintree Capital, LLC
- $9.13 Billion
- Q1 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Insulet Corp stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 1,900 shares of PODD stock, worth $614,745. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,900
Previous 1,244
52.73%
Holding current value
$614,745
Previous $324,000
53.7%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PODD
# of Institutions
791Shares Held
63.2MCall Options Held
379KPut Options Held
548K-
Vanguard Group Inc Valley Forge, PA8.67MShares$2.8 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.08MShares$1.97 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.96 Billion0.03% of portfolio
-
State Street Corp Boston, MA3.02MShares$978 Million0.03% of portfolio
-
Baillie Gifford & CO2.25MShares$728 Million0.53% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $22.5B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...